Document ID: chunk:federal_register_of_legislation:F2023L01174:reg:9:p3
Version: federal_register_of_legislation:F2023L01174
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9199–11569

clinical onset of malignant neoplasm of the breast;
(17)      for death from malignant neoplasm of the breast only, for females aged 50 to 69 years, being prevented from accessing mammographic screening for malignant neoplasm of the breast in accordance with contemporary medical standards at the time, within the 10 years before the clinical onset of malignant neoplasm of the breast, and where:
             (a)          if mammographic screening has been resumed in the interim, there has been no normal test result; and
             (b)          the opportunity for subsequent appropriate mammographic screening has not been declined;
(18)      taking digoxin, digitalis or digitoxin for a continuous period of at least 1 year before the clinical onset of malignant neoplasm of the breast, and if taking digoxin, digitalis or digitoxin has ceased before the clinical onset of malignant neoplasm of the breast, then that onset occurred within 5 years of cessation;
(19)      inhaling ethylene oxide vapour:
             (a)          at an ambient 8-hour time-weighted average concentration of at least 1.5 parts per million for a cumulative total of at least 2,500 hours within a continuous period of 10 years before the clinical onset of malignant neoplasm of the breast; or
             (b)          in an amount greater than 10 ppm-years of cumulative exposure before the clinical onset of malignant neoplasm of the breast; and
where the first exposure occurred at least 5 years before the clinical onset of malignant neoplasm of the breast;
Note 1: Inhalation of ethylene oxide vapour can occur during the sterilisation of surgical instruments or protective clothing in hospitals.
Note 2: 8-hour time-weighted average and ppm-years are defined in the Schedule 1 - Dictionary.
(20)      undertaking night shift work:
             (a)          on at least 3 nights per week for a minimum of 10 hours per shift; and
             (b)          for a continuous period of at least 5 years before the clinical onset of malignant neoplasm of the breast; and
if night shift work has ceased before the clinical onset of malignant neoplasm of the breast, then that onset occurred within 3 years of cessation;
(21)      inability to obtain appropriate clinical management for malignant neoplasm of the breast before the clinical worsening of malignant neoplasm of the breast.